US obesity rates have shown a statistically significant decline for the first time in years, coinciding with a sharp rise in the use of GLP-1 receptor agonist drugs, according to new findings from Gallup’s National Health and Well-Being Index…
US Obesity Rates Decline in Tandem With Rise in Use of GLP-1 RA, New Gallup Index Shows
